285 related articles for article (PubMed ID: 6459843)
1. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
2. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
Ratko TA; Detrisac CJ; Dinger NM; Thomas CF; Kelloff GJ; Moon RC
Cancer Res; 1989 Aug; 49(16):4472-6. PubMed ID: 2525951
[TBL] [Abstract][Full Text] [Related]
6. Influence of delayed administration of retinyl acetate on mammary carcinogenesis.
McCormick DL; Moon RC
Cancer Res; 1982 Jul; 42(7):2639-43. PubMed ID: 7083156
[TBL] [Abstract][Full Text] [Related]
7. Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
McCormick DL; Moon RC
Carcinogenesis; 1986 Feb; 7(2):193-6. PubMed ID: 2936526
[TBL] [Abstract][Full Text] [Related]
8. Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis.
Cohen LA; Epstein M; Saa-Pabon V; Meschter C; Zang E
Nutr Cancer; 1994; 21(3):271-83. PubMed ID: 8072880
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
Verma AK; Johnson JA; Gould MN; Tanner MA
Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
[TBL] [Abstract][Full Text] [Related]
10. Effect of retinyl acetate on the occurrence of ovarian hormone-responsive and -nonresponsive mammary cancers in the rat.
Thompson HJ; Meeker LD; Tagliaferro AR; Becci PJ
Cancer Res; 1982 Mar; 42(3):903-5. PubMed ID: 6800647
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis by concomitant or postcarcinogen antioxidant exposure.
McCormick DL; Major N; Moon RC
Cancer Res; 1984 Jul; 44(7):2858-63. PubMed ID: 6426789
[TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
[TBL] [Abstract][Full Text] [Related]
13. Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat.
Thompson HJ; Becci PJ; Brown CC; Moon RC
Cancer Res; 1979 Oct; 39(10):3977-80. PubMed ID: 476636
[TBL] [Abstract][Full Text] [Related]
14. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM
Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636
[TBL] [Abstract][Full Text] [Related]
15. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.
Alshafie GA; Harris RE; Robertson FM; Parrett ML; Ross M; Abou-Issa H
Anticancer Res; 1999; 19(4B):3031-6. PubMed ID: 10652588
[TBL] [Abstract][Full Text] [Related]
16. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.
Abou-Issa H; Curley RW; Alshafie GA; Weiss KL; Clagett-Dame M; Chapman JS; Mershon SM
Anticancer Res; 2001; 21(6A):3839-44. PubMed ID: 11911255
[TBL] [Abstract][Full Text] [Related]
19. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats.
McCormick DL; Rao KV; Dooley L; Steele VE; Lubet RA; Kelloff GJ; Bosland MC
Cancer Res; 1998 Aug; 58(15):3282-8. PubMed ID: 9699656
[TBL] [Abstract][Full Text] [Related]
20. Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms.
Parrett ML; Abou-Issa HM; Alshafie G; Ross MS; Harris RE; Robertson FM
Anticancer Res; 1999; 19(6B):5079-85. PubMed ID: 10697514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
